Why is Astrazeneca Phar falling/rising?

As of 22-Jul, Astrazeneca Pharma India Ltd's stock price is currently at Rs 9,028.00, reflecting a decrease of Rs 100.0, or 1.1%. Today's price summary indicates that the stock touched an intraday low of Rs 8,931, which is a decline of 2.16%. While the stock has shown strong performance over the longer term, with a year-to-date increase of 23.08% and a 44.70% rise over the past year, it has recently experienced a decline of 1.64% over the past week. Positive factors contributing to the stock's overall strength include high management efficiency, a low debt-to-equity ratio, and significant growth in net profit, which was reported at 88.82%. However, the stock faces challenges such as poor long-term growth prospects and a high valuation compared to peers, which may be contributing to the recent price drop.
In the broader market context, Astrazeneca's short-term performance has underperformed the benchmark, with a weekly decline of 1.64% compared to the Sensex's smaller drop of 0.47%. This suggests that while the stock has been strong over the long term, recent investor participation has fallen, as evidenced by a 32.56% decrease in delivery volume against the five-day average. Additionally, a slight reduction in institutional investor stakes may indicate a lack of confidence among larger investors, which could further impact the stock's price movement.